OBJECTIVE: To determine the effect of various treatments for @entity1067 ( @entity1067 ) on sexual function. @entity1 AND METHODS: In a longitudinal multicentre study carried out in the Netherlands, 670 consecutive @entity1 with @entity1067 (aged > or = 50 years) were examined at baseline and 9 months after inclusion. All @entity1 completed a questionnaire about symptomatology, bothersomeness and sexual function before and after treatment. Other diagnostic information was retrieved from the medical records. RESULTS: At baseline, 49-59% of the population (mean age 66 years) reported normal potency and 69% a normal libido. Outcomes at 9 months were stratified by type of treatment, i.e. surgery in 207, alpha-blockers in 43, @entity585 in 47 and watchful waiting in 234 @entity1 . @entity1 with multiple or other treatments (131) or recent surgery (eight) were excluded from the analyses. For the four sexual items included, 84% of the @entity1 reported no changes. All treatments showed both improvement and deterioration in 3-14% and 0-16% of the @entity1 , respectively. CONCLUSION: For sexual function, most @entity1 remained stable after treatment for @entity1067 , while positive and negative changes occurred in equal proportions for all treatments. These results question the previously reported high incidence of sexual adverse events, particularly after surgical intervention.

Sexual function before and after various treatments for symptomatic XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'PATIENTS', 'men'] @entity1067 :: ('MESH:D011470', 'Disease') :: ['benign prostatic hyperplasia', 'BPH'] @entity585 :: ('MESH:D018120', 'Chemical') :: ['finasteride']
@entity1067 :: (MESH:D011470,Disease) :: ['benign prostatic hyperplasia']
